Literature DB >> 29569027

Polymeric nanoparticles for topical delivery of alpha and beta arbutin: preparation and characterization.

Nursyafiqah Sahrum Ayumi1, Shariza Sahudin2, Zahid Hussain1, Mumtaz Hussain1, Nor Hayati Abu Samah1.   

Abstract

To investigate the use of chitosan nanoparticles (CS-TPP-NPs) as carriers for α- and β-arbutin. In this study, CS-TPP-NPs containing α- and β-arbutin were prepared via the ionic cross-linking of CS and TPP and characterized for particle size, zeta potential, and dispersity index. The entrapment efficiency and loading capacity of various β-arbutin concentrations (0.1, 0.2, 0.4, 0.5, and 0.6%) were also investigated. SEM, TEM FTIR, DSC and TGA analyses of the nanoparticles were performed to further characterize the nanoparticles. Finally, stability and release studies were undertaken to ascertain further the suitability of the nanoparticles as a carrier system for α- and β-arbutin. Data obtained clearly indicates the potential for use of CS-TPP-NPs as a carrier for the delivery of α- and β-arbutin. The size obtained for the alpha nanoparticles (α-arbutin CSNPs) ranges from 147 to 274 d.nm, with an increase in size with increasing alpha arbutin concentration. β-arbutin nanoparticles (β-arbutin CSNPs) size range was from 211.1 to 284 dn.m. PdI for all nanoparticles remained between 0.2-0.3 while the zeta potential was between 41.6-52.1 mV. The optimum encapsulation efficiency and loading capacity for 0.4% α-arbutin CSNPs were 71 and 77%, respectively. As for β-arbutin, CSNP optimum encapsulation efficiency and loading capacity for 0.4% concentration were 68 and 74%, respectively. Scanning electron microscopy for α-arbutin CSNPs showed a more spherical shape compared to β-arbutin CSNPs where rod-shaped particles were observed. However, under transmission electron microscopy, the shapes of both α- and β-arbutin CSNP nanoparticles were spherical. The crystal phase identification of the studied samples was carried out using X-ray diffraction (XRD), and the XRD of both α and β-arbutin CSNPs showed to be more crystalline in comparison to their free form. FTIR spectra showed intense characteristic peaks of chitosan appearing at 3438.3 cm-1 (-OH stretching), 2912 cm-1 (-CH stretching), represented 1598.01 cm-1 (-NH2) for both nanoparticles. Stability studies conducted for 90 days revealed that both α- and β-arbutin CSNPs were stable in solution. Finally, release studies of both α- and β-arbutin CSNPs showed a significantly higher percentage release in comparison to α- and β-arbutin in their free form. Chitosan nanoparticles demonstrate considerable promise as a carrier system for α- and β-arbutin, the use of which is anticipated to improve delivery of arbutin through the skin, in order to improve its efficacy as a whitening agent.

Entities:  

Keywords:  Chitosan nanoparticles; Ionic gelation; Whitening agent; α-arbutin; β-arbutin

Mesh:

Substances:

Year:  2019        PMID: 29569027     DOI: 10.1007/s13346-018-0508-6

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  47 in total

Review 1.  Chitosan: some pharmaceutical and biological aspects--an update.

Authors:  A K Singla; M Chawla
Journal:  J Pharm Pharmacol       Date:  2001-08       Impact factor: 3.765

2.  Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release.

Authors:  Quan Gan; Tao Wang
Journal:  Colloids Surf B Biointerfaces       Date:  2007-04-24       Impact factor: 5.268

3.  Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.

Authors:  A Anitha; S Maya; N Deepa; K P Chennazhi; S V Nair; R Jayakumar
Journal:  J Biomater Sci Polym Ed       Date:  2012-05-08       Impact factor: 3.517

4.  Self-assembled polymeric nanoparticles for percutaneous co-delivery of hydrocortisone/hydroxytyrosol: an ex vivo and in vivo study using an NC/Nga mouse model.

Authors:  Zahid Hussain; Haliza Katas; Mohd Cairul Iqbal Mohd Amin; Endang Kumolosasi; Fhataheya Buang; Shariza Sahudin
Journal:  Int J Pharm       Date:  2013-01-18       Impact factor: 5.875

5.  Screening of high α-arbutin producing strains and production of α-arbutin by fermentation.

Authors:  Chun-Qiao Liu; Li Deng; Peng Zhang; Shu-Rong Zhang; Luo Liu; Tao Xu; Fang Wang; Tian-Wei Tan
Journal:  World J Microbiol Biotechnol       Date:  2013-03-01       Impact factor: 3.312

6.  Chitosan nanoparticles as delivery systems for doxorubicin.

Authors:  K A Janes; M P Fresneau; A Marazuela; A Fabra; M J Alonso
Journal:  J Control Release       Date:  2001-06-15       Impact factor: 9.776

7.  Novel self-assembled core-shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release.

Authors:  Sofia Papadimitriou; Dimitrios Bikiaris
Journal:  J Control Release       Date:  2009-05-14       Impact factor: 9.776

8.  Inhibitory effects of alpha-arbutin on melanin synthesis in cultured human melanoma cells and a three-dimensional human skin model.

Authors:  Kazuhisa Sugimoto; Takahisa Nishimura; Koji Nomura; Kenji Sugimoto; Takashi Kuriki
Journal:  Biol Pharm Bull       Date:  2004-04       Impact factor: 2.233

Review 9.  Recent advances of chitosan nanoparticles as drug carriers.

Authors:  Jun Jie Wang; Zhao Wu Zeng; Ren Zhong Xiao; Tian Xie; Guang Lin Zhou; Xiao Ri Zhan; Shu Ling Wang
Journal:  Int J Nanomedicine       Date:  2011-04-11

10.  Applications of nanoparticles in biology and medicine.

Authors:  OV Salata
Journal:  J Nanobiotechnology       Date:  2004-04-30       Impact factor: 10.435

View more
  3 in total

1.  Effect of ligustrazine nanoparticles on Th1/Th2 balance by TLR4/MyD88/NF-κB pathway in rats with postoperative peritoneal adhesion.

Authors:  Lili Yang; Ziyu Lian; Bin Zhang; Zhengjun Li; Li Zeng; Wenlin Li; Yaoyao Bian
Journal:  BMC Surg       Date:  2021-04-26       Impact factor: 2.102

2.  Design and Optimization of Cationic Nanocapsules for Topical Delivery of Tretinoin: Application of the Box-Behnken Design, In Vitro Evaluation, and Ex Vivo Skin Deposition Study.

Authors:  Saeed Ebrahimi; Reza Mahjub; Rasool Haddadi; Seyed Yaser Vafaei
Journal:  Biomed Res Int       Date:  2021-12-12       Impact factor: 3.411

3.  Functionalized chitosan nanoparticles for cutaneous delivery of a skin whitening agent: an approach to clinically augment the therapeutic efficacy for melasma treatment.

Authors:  Shymaa Hatem; Seham A Elkheshen; Amany O Kamel; Maha Nasr; Noha H Moftah; Maha H Ragai; Reham S Elezaby; Nada M El Hoffy
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.